Detalles de la búsqueda
1.
SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.
Cancer
; 130(3): 476-484, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37823514
2.
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Cancer
; 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294959
3.
Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.
Gynecol Oncol
; 172: 92-97, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003073
4.
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.
Curr Oncol Rep
; 25(5): 433-444, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811807
5.
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy.
Oncologist
; 27(9): 799-808, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666292
6.
Montelukast in hospitalized patients diagnosed with COVID-19.
J Asthma
; 59(4): 780-786, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577360
7.
Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic review.
Gynecol Oncol
; 159(2): 573-580, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32917412
8.
Breast Reconstruction Complications After Postmastectomy Proton Radiation Therapy for Breast Cancer.
Adv Radiat Oncol
; 9(3): 101385, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38495035
9.
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors.
Int J Radiat Oncol Biol Phys
; 118(5): 1435-1444, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37866762
10.
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC.
Radiother Oncol
; 190: 110030, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008414
11.
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression.
Clin Lung Cancer
; 25(1): 50-60.e6, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37813713
12.
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.
Radiother Oncol
; 190: 110005, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37972736
13.
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation.
Int J Radiat Oncol Biol Phys
; 118(5): 1445-1454, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619788
14.
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 119(1): 56-65, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652303
15.
One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia.
Heart Rhythm
; 21(1): 18-24, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827346
16.
A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers.
Surg Oncol Clin N Am
; 32(3): 433-459, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182986
17.
Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach.
Cancers (Basel)
; 15(13)2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444636
18.
Factors Associated With Travel Distance in the Receipt of Proton Breast Radiation Therapy.
Int J Part Ther
; 9(3): 1-9, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721480
19.
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 24(2): e78-e86, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628846
20.
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Clin Transl Radiat Oncol
; 39: 100587, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36718252